Introduction
Obesity and the prevalence of type II diabetes are increasing worldwide and can be found in ever-younger age groups, which is expected to lead to ever-younger premature cardiovascular morbidity. This is a serious public-health problem. The accurate presymptomatic detection of high-risk individuals is crucial for the effectiveness of prevention strategies. The increasing evidence that low-grade inflammation is associated with obesity and metabolic dysfunction, which links causally to insulin resistance and the metabolic syndrome [1, 2 ] , suggests that the importance of inflammatory markers during the preclinical phase of cardiovascular disease and type II diabetes should be explored.
Inflammation underlies disease processes from an early age
Inflammation is a key function in the process by which the body responds to an injury or an infection, and the acute phase of inflammation normally leads to recovery from infection and to healing and to a return to normal values within a few days. If the response is not properly phased, however, the process can develop into a chronic low-grade inflammatory state that may trigger different diseases under pathological conditions [1, 2 ] . Prospective studies in adults have shown that chronic low-grade inflammation may contribute to the pathogenesis of diseases such as atherosclerosis [3, 4] , type I and type II diabetes [1,2 ], cancer [5] , several types of neurodegenerative disorders [6] and autoimmune diseases [7] .
Atherosclerosis is now widely accepted as a chronic inflammatory disease that is initiated by vascular injury induced by damaging agents such as oxidized LDL, reactive oxygen species and infection [3, 4] . Although patients with cardiovascular disease typically become symptomatic after the age of 40, atherosclerotic changes in the vessel wall and the onset of fatty infiltration of the vasculature start early in life [8, 9] . Inflammation has been associated with early arterial changes and promotion of intima-media thickening in healthy [10] as well as in obese children [11 ] , supporting the hypothesis that inflammation also plays a role in the pathogenesis of early atherosclerosis. Furthermore, the atherosclerotic process is accelerated in children presenting multiple risk factors [12] . Attention is now focusing on the identification and evaluation of plasma markers for the reliable Purpose of review The prevalence of overweight and the metabolic syndrome is increasing in young people. This review aims to summarize current research in children and adolescents on inflammatory markers related to components of the metabolic syndrome.
Recent findings
Obesity is characterized by a state of low-grade inflammation at all ages. Body fat has been shown to correlate with the various components of the metabolic syndrome. There is evidence to show that chronic subclinical inflammation in childhood and adolescence is associated with metabolic dysfunction, which can lead to insulin resistance and the metabolic syndrome.
Summary
The results presented in this review highlight the underlying inflammatory mechanisms of the early stages of metabolic disorders related to obesity. The preclinical phases of diabetes and cardiovascular disease last many decades, and this feature of the diseases provides an opportunity for the early identification of target groups and the use of appropriate prevention strategies while the pathological processes are still completely reversible.
Keywords acute-phase proteins, diabetes type II, lifestyle, obesity noninvasive detection of high-risk young subjects during the long presymptomatic phase of the disease, when early endothelial changes are entirely reversible [13] .
Several parameters of the inflammatory reaction can be measured in plasma. We focus on the inflammatory markers that have been hypothesized to be associated with obesity or the metabolic syndrome in young populations. These markers of inflammation include acutephase proteins, pro-inflammatory cytokines, adhesion molecules and adipokines (proteins secreted by adipose tissue). C-reactive protein (CRP) is an acute-phase reactant and a very sensitive marker of inflammation and has now emerged as one of the most powerful predictors of cardiovascular risk. In a direct comparison of several inflammatory and lipid markers in predicting cardiovascular events in adults, CRP surpassed other classical risk markers, including LDL cholesterol, at least in some, though not in all, studies [14] . Most studies use CRP as the only marker of inflammation. Choosing a wider spectrum of inflammatory markers, however, can give us a better picture of the specific mechanisms involved [15] .
Other commonly used acute-phase reactants include complement factors C3 and C4, serum amyloid A and ceruloplasmin. TNF-a and IL-6 are important cytokines, which have been associated with obesity and components of the metabolic syndrome. The endothelial expression of vascular adhesion molecule VCAM-1 and intracellular adhesion molecules ICAM-1 and E-selectin are used as markers of the filtration of inflammatory cells into the arterial wall. Of the adipokines, the most studied is adiponectin [1, 16] .
Inflammation is associated with components of the metabolic syndrome in adolescents
The metabolic syndrome in adults is defined as a cluster of risk factors for cardiovascular disease and type II diabetes, which include abdominal obesity, dyslipidaemia, glucose intolerance and hypertension. Although there is increasing evidence to show that subclinical inflammation is associated with obesity and metabolic dysfunction [1,2 ], markers of inflammation, such as CRP, are not considered in the practical diagnosis of the metabolic syndrome in adults or in children and adolescents [17] . Understanding the associations of the component conditions of the metabolic syndrome with inflammation in the early stages of the disease might help in designing future studies that could target atherosclerosis and inflammation in young populations.
We examine the association of the metabolic syndrome and some of its component conditions with inflammatory markers that have been recently studied in adolescents.
Obesity-induced inflammation
Adipose tissue is now widely recognized as having endocrine functions [18] . The continued identification of bioactive proteins secreted by the adipose tissue, so-called adipokines, supports the theory that excess adiposity plays a central role in the metabolic syndrome and in insulin resistance [1,2 ,16] . Adipokines locally produced in the adipose tissue seem to increase the hepatic synthesis of acute-phase inflammatory proteins (e.g. CRP, complement factors, serum amyloid A).
Several large-scale population-based studies in children and adolescents have shown higher levels of CRP in overweight subjects than in those of normal weight [19] [20] [21] . Serum IL-6 has, in several studies, been shown to correlate with body fat [11 ,22 ,23-25] . Raised TNF-a concentrations in overweight subjects are not a consistent finding; some studies have found elevated concentrations [23, 26, 27] , while others have not [22 ,28,29 ] . Other markers that have been shown to be higher in childhood and adolescent obesity are soluble TNF-a receptors [24, 27, 28] , adhesion molecules sICAM-1, sVCAM-1 and E-selectin [11 ,30] , and adiponectin (negatively) [24,29 , 31,32,33 ] .
The Spanish adolescent population has a high prevalence of overweight, including central obesity [34] . The AVENA study (Alimentació n y Valoració n del Estado Nutricional en Adolescentes or Evaluation of Food Intake and Nutritional Status in Adolescents) is a cross-sectional multicentre school-based study, involving 500 adolescents between 13 and 18 years of age, who provided blood for analysis and biochemical and immunological assessment [19, 35 ] . In this study, we found higher CRP levels in the overweight subjects than in their leaner peers. In this same study, ceruloplasmin also correlated with body fat, but only in females [19] . Complement factors C3 and C4 correlated more with body fat than did CRP [35 ] . Interestingly, C3 was associated with waist circumference, independently of total body fat, suggesting an anti-inflammatory effect of abdominal fat mediated by C3. An important question to answer is how adiposity regulates inflammation during childhood and adolescent overweight and obesity, in order to increase our understanding of the possible mechanisms in related diseases.
We should not forget that debates are ongoing regarding inflammation and whether it causes damage or is merely a marker of adiposity, and whether observed associations could be epiphenomena of underlying obesity-related disease processes. A recent study in childhood obesity demonstrates that the elementary lesion in early obesity is a microgranuloma with lipodegenerative aspects [36 ] . The authors conclude that it is the result of adipocyte fragility and a consequent recruitment of macrophages; this process then leads to a moderate fibrosis. This lesion could be a mechanistic explanation for the maintenance of the inflammatory state that characterizes obesity. Finally, we should bear in mind that the serum values of inflammatory proteins that are discussed in epidemiological studies in children and adolescents are always within normal ranges, which implies that the populations are healthy but that chronically high-normal values may be clinically significant in the long term.
Metabolic dysfunction and inflammation
In adults, the measurement of CRP in addition to lipid screening is recommended by some but not all authorities for coronary risk prediction, due to the fact that higher ranges of CRP levels are related to higher risk. A consensus statement of the Centers for Disease Control and the American Heart Association categorized CRP levels in the general adult population that were higher than 3 mg/l as high risk, 1-3 mg/l as intermediate risk and lower than 1 mg/l as low risk [37] . Using these cut-offs, the prevalence of low risk, intermediate risk and high risk in a sample of nationally representative healthy Spanish adolescents (from the previously mentioned AVENA study) was 68%, 23% and 7%, respectively. Concentrations ranged from 0.04 to 47.37 mg/l, with a median of 0.64 mg/l [38 ] . Two per cent of the adolescents had CRP levels higher than 10 mg/l, which was most probably due to an ongoing acute-phase response to infectious disease or an immune disorder characterized by acute inflammation. In research on chronic inflammation, however, to minimize the confounder of an ongoing infection, subjects with values higher than 10 mg/l should be excluded from analyses or studied separately.
Guran et al. [39 ] determined CRP cut-off values intended to reliably identify children with cardiovascular-disease risk factors (hypercholesteroalemia, hypertension, obesity, low HDL cholesterol and familial history of cardiovascular disease). This study compared 51 children (mean age 12 years) with risk factors with 26 children (mean age 13 years) without any risk factors. CRP concentrations greater than 1.04 mg/l predicted the presence of cardiovascular risk factors with 58% sensitivity and 92% specificity.
Case-control and cross-sectional studies have shown elevated CRP in children and adolescents with components of the metabolic syndrome (e.g. abdominal adiposity, fasting insulin, dyslipidaemia and blood pressure) [22 ,31,35 ,39 ,40-44] . The CRP concentrations are generally increased in subjects with three or more risk factors [44] . It must be borne in mind that obesity is the main determinant of inflammation in all studies and the relative implication of each one of the components may be difficult to disaggregate when they cluster together in a metabolic disorder. A few studies in children and adolescents have specifically studied the relationship between inflammatory markers and fasting insulin levels and/or insulin resistance: CRP [11 ,21,24,43,45,46] , IL-6 [24, 25, 28, 29 ] , IL-18 [11 ,29 ] , TNF-a [27, 47] , adhesion molecules [11 ] , as well as adiponectin [24,29 ,31,32, 33 ] .
Insulin: an anti-inflammatory hormone?
Recent observations in in-vitro studies and in-vivo in adults have shown a pro-inflammatory effect of glucose and an anti-inflammatory action of insulin [1,2 ,16]. These observations have led to a working hypothesis explaining how the pro-inflammatory state that accompanies the metabolic syndrome associates with both insulin resistance and endothelial dysfunction, via the connection between inflammation and metabolic processes. This hypothesis may also be relevant to the association between insulin-resistant states (like obesity and type 2 diabetes) and oxidative stress, inflammation and atherosclerosis.
Modifiable lifestyle determinants: diet and physical activity
Preventive measures against inflammation in young people, as well as in adults, relate to lifestyle factors such as dietary habits and physical activity levels. We have recently summarized published data on the relationships between lifestyle-related determinants (i.e. overweight, physical activity and dietary habits) and inflammatory markers in apparently healthy young populations [38 ] . As we have seen throughout this review, body fat seems to be the main determinant of inflammation. Diet and physical activity, however, are the main modifiable risk factors of obesity and therefore offer a potential therapeutic approach to modulate low-grade inflammation. Research into modulation of inflammatory processes by diet [22 ,38 ,48,49] and physical fitness [23,24,38 ,42, 50-57] is beginning to be explored in children and adolescents, but no definitive conclusions can be currently reached.
Conclusion
CRP has been associated with all components of the metabolic syndrome in children and adolescents, and with an increased risk of future cardiovascular disease and diabetes mellitus in adulthood. Although body fat is the strongest determinant of low-grade inflammation, the association between inflammation and other components of the metabolic syndrome are not explained by obesity alone, and this may support the theory that obesityrelated diseases develop at an early preclinical stage. If such an interrelationship exists, it raises the possibility of using markers of low-grade inflammation for screening high-risk young subjects during the long presymptomatic
